Atomo Diagnostics Secures US$6M Investment from The Global Health Investment Fund
The Global Health Investment Fund (GHIF) announced today that it has provided a US$6 million [A$8.5 million] loan to Atomo Diagnostics (Atomo) to support scale-up of Atomo’s production operations and expansion of commercial activities related to the AtomoRapid™ rapid diagnostic test (RDT) platform. Funds will also be used to commercialise a self-test solution for HIV and other infectious diseases. - January 16, 2016
Sydney Company Wins State Funding to Make HIV Self Test
Atomo Diagnostics awarded A$1.8 mil from the NSW Medical Device Fund to develop innovative HIV self test in Australia. - November 28, 2015
Press Releases 1 - 2 of 2